Compare Mattel Inc (MAT) vs Oruka Therapeutics Inc. Common Stock (ORKA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Mattel Inc vs Oruka Therapeutics Inc. Common Stock — how do they compare? Mattel Inc trades at $16.65 (market cap $4.80B), while Oruka Therapeutics Inc. Common Stock trades at $75.2 (market cap $5.18B). The key difference: Mattel Inc and Oruka Therapeutics Inc. Common Stock are close in size by market cap, and Oruka Therapeutics Inc. Common Stock is trading nearer its 52-week high, Mattel Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Mattel Inc for 97 Days and Oruka Therapeutics Inc. Common Stock for 0 Days on average.
| MAT | ORKA | |
|---|---|---|
Market Cap | $4.80B | $5.18B |
Volume | 4,615,998 | 490,798 |
Sector | Consumer Cyclical | Health |
52-Week High | $22.16 | $113.08 |
52-Week Low | $12.66 | $26.19 |
Typical Hold Time | 97 Days | 0 Days |
Enterprise Value | $7.02B | $4.31B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Mattel (MAT) trades at $16.65, down 0.66% with mixed technical signals showing bullish moving averages but overbought RSI levels. The company maintains stable revenue around $5.3-5.5B with 7.78% net margins and attractive valuation ratios (P/E 12.53, P/S 0.93). Recent CEO transition and takeover interest from Authentic Brands Group create significant near-term catalysts, though earnings have shown volatility with two recent quarterly misses.
The stock presents a compelling risk-reward with strong brand portfolio and takeover speculation offsetting execution risks during leadership transition. Analyst consensus leans bullish (54% buy ratings) with $16.25 price target, though investors should monitor new CEO's strategic direction and Barbie sales stabilization. Cash flow volatility and debt levels ($2.33B) remain key watchpoints.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Mattel Inc
Mattel markets toy products that are sold to its wholesale customers and direct to retail consumers. The company offers products for children and families, including toys for infants and preschoolers, girls and boys, youth electronics, handheld and other games, puzzles, educational toys, media-driven products, and plush and fashion-related toys. Mattel's owned portfolio includes Barbie, Hot Wheels, Fisher-Price, Thomas & Friends, and American Girl. In addition, it currently manufactures toy products for its segments both internally and externally (through manufacturing partners). Just over half of its net sales are in North America, while the remainder stem from international markets.
Read more on MAT →About Oruka Therapeutics Inc. Common Stock
Oruka Therapeutics, Inc. is a clinical-stage biotechnology company developing extended half-life monoclonal antibodies for plaque psoriasis, psoriatic arthritis, and related dermatologic conditions, with lead candidates ORKA-001 and ORKA-002 in clinical trials.
Read more on ORKA →
